Julie Asch

414 total citations
24 papers, 295 citations indexed

About

Julie Asch is a scholar working on Oncology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Julie Asch has authored 24 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Infectious Diseases and 8 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Julie Asch's work include Acute Lymphoblastic Leukemia research (8 papers), Microscopic Colitis (6 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Julie Asch is often cited by papers focused on Acute Lymphoblastic Leukemia research (8 papers), Microscopic Colitis (6 papers) and Clostridium difficile and Clostridium perfringens research (6 papers). Julie Asch collaborates with scholars based in United States, Canada and Netherlands. Julie Asch's co-authors include Clyde D. Ford, Bert K. Lopansri, Finn Bo Petersen, Daanish Hoda, Merideth M Wendland, David K. Gaffney, Michael A. Pulsipher, John W. Thomson, Gregory L. Snow and John P. Burke and has published in prestigious journals such as Blood, Cancer and Infection Control and Hospital Epidemiology.

In The Last Decade

Julie Asch

21 papers receiving 289 citations

Peers

Julie Asch
B Arora India
Çiğdem Pala Türkiye
W. Mark Roberts United States
E Kaiserová Slovakia
J M Mukiibi Zimbabwe
B Arora India
Julie Asch
Citations per year, relative to Julie Asch Julie Asch (= 1×) peers B Arora

Countries citing papers authored by Julie Asch

Since Specialization
Citations

This map shows the geographic impact of Julie Asch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Asch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Asch more than expected).

Fields of papers citing papers by Julie Asch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Asch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Asch. The network helps show where Julie Asch may publish in the future.

Co-authorship network of co-authors of Julie Asch

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Asch. A scholar is included among the top collaborators of Julie Asch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Asch. Julie Asch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ford, Clyde D., Bert K. Lopansri, Bradley D. Hunter, Julie Asch, & Daanish Hoda. (2024). Multiplexed Gastrointestinal PCR Panels for the Evaluation of Diarrhea in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 30(8). 814.e1–814.e7. 6 indexed citations
2.
Hunter, Bradley D., Daanish Hoda, Julie Asch, & Prashant K. Sharma. (2024). The “Walk through the Clinic Door” Effect: Differences in Survival and Toxicity Based on Site of CAR T Administration in a Default Outpatient CAR T Program. Blood. 144(Supplement 1). 1749–1749.
3.
Ford, Clyde D., Bert K. Lopansri, Bradley D. Hunter, et al.. (2024). Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia. Infection Control and Hospital Epidemiology. 46(1). 77–80. 1 indexed citations
5.
Ford, Clyde D., Bert K. Lopansri, Jana Coombs, et al.. (2022). Extended spectrum cephalosporin resistant enterobacteriaceae carriage and infection in patients admitted with newly-diagnosed acute leukemia. American Journal of Infection Control. 51(2). 172–177. 2 indexed citations
6.
Ueda, Masumi, Barry E. Storer, Huiying Qiu, et al.. (2020). Long-term Outcomes with Nonmyeloablative HLA-Identical Related Hematopoietic Cell Transplantation Using Tacrolimus and Mycophenolate Mofetil for Graft-versus-Host Disease Prophylaxis. Transplantation and Cellular Therapy. 27(2). 163.e1–163.e7.
7.
Ford, Clyde D., Bert K. Lopansri, Jana Coombs, et al.. (2020). Are Clostridioides difficile infections being overdiagnosed in hematopoietic stem cell transplant recipients?. Transplant Infectious Disease. 22(4). e13279–e13279. 8 indexed citations
8.
Ford, Clyde D., Jana Coombs, Michaela A. Gazdik, et al.. (2019). Decrease in vancomycin-resistantEnterococcuscolonization associated with a reduction in carbapenem use as empiric therapy for febrile neutropenia in patients with acute leukemia. Infection Control and Hospital Epidemiology. 40(7). 774–779. 12 indexed citations
9.
Ford, Clyde D., Bert K. Lopansri, Brandon Webb, et al.. (2018). Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: Incidence, risk factors, and patient outcomes. American Journal of Infection Control. 47(4). 394–399. 13 indexed citations
10.
Patel, Shiven B., Clinton C. Mason, Martha Glenn, et al.. (2017). Genomic analysis of adult B-ALL identifies potential markers of shorter survival. Leukemia Research. 56. 44–51. 12 indexed citations
11.
Fathi, Amir T., Daniel J. DeAngelo, Kristen E. Stevenson, et al.. (2016). Phase 2 study of intensified chemotherapy and allogeneic hematopoietic stem cell transplantation for older patients with acute lymphoblastic leukemia. Cancer. 122(15). 2379–2388. 22 indexed citations
13.
DeAngelo, Daniel J., Kristen E. Stevenson, Donna Neuberg, et al.. (2015). A Multicenter Phase II Study Using a Dose Intensified Pegylated-Asparaginase Pediatric Regimen in Adults with Untreated Acute Lymphoblastic Leukemia: A DFCI ALL Consortium Trial. Blood. 126(23). 80–80. 37 indexed citations
14.
Fathi, Amir T., Daniel J. DeAngelo, Kristen E. Stevenson, et al.. (2014). Intensified Chemotherapy for Older Patients with Acute Lymphoblastic Leukemia (ALL): A Phase II Study from the Dana Farber Cancer Institute (DFCI) ALL Consortium. Blood. 124(21). 3714–3714. 2 indexed citations
15.
Wendland, Merideth M, Kenneth M. Boucher, Julie Asch, et al.. (2007). The Impact of Involved Field Radiation Therapy in the Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma With High-Dose Chemotherapy Followed by Hematopoietic Progenitor Cell Transplant. American Journal of Clinical Oncology. 30(2). 156–162. 16 indexed citations
16.
Wendland, Merideth M, Julie Asch, Michael A. Pulsipher, et al.. (2006). The Impact of Involved Field Radiation Therapy for Patients Receiving High-Dose Chemotherapy Followed by Hematopoietic Progenitor Cell Transplant for the Treatment of Relapsed or Refractory Hodgkin Disease. American Journal of Clinical Oncology. 29(2). 189–195. 27 indexed citations
18.
Kasow, Kimberly A., Carmem Bonfim, Julie Asch, et al.. (2003). Malignant infantile osteopetrosis & primary pulmonary hypertension: A new combination?. Pediatric Blood & Cancer. 42(2). 190–194. 11 indexed citations
19.
Nosher, John L., Leonard J. Bodner, Lawrence J. Ettinger, et al.. (2001). Radiologic Placement of a Low Profile Implantable Venous Access Port in a Pediatric Population. CardioVascular and Interventional Radiology. 24(6). 395–399. 19 indexed citations
20.
Asch, Julie, et al.. (1998). Retroviral gene transfer into cord blood stem/progenitor cells using purified vector stocks. American Journal of Hematology. 57(1). 16–23. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026